Abstract Evaluation of the metabolome could discover novel biomarkers of disease. To date,
characterization of the serum metabolome of client-owned cats with chronic kidney disease …

Chronic kidney disease (CKD) is characterised by progressive kidney damage and
encompasses a broad range of renal pathologies and aetiologies. In humans, CKD is an …

Biomarkers allow for noninvasive detection of organ damage or dysfunction. For renal
disease, commercially available biomarkers that are both widely available and commonly …

Simple Summary Fibroblast growth factor-23 (FGF-23) is used to monitor chronic kidney
disease in humans. The value of FGF-23 in cats is largely unknown. The aim of this study …

Materials and Methods: Forty-eight client-owned azotemic cats (creatinine> 250 μmol/L)
were included in this prospective study. Cats with pre-and post-renal azotemia were …

Objectives Oxidative stress is associated with the development and progression of chronic
kidney disease (CKD) in humans. The aim of this study was to evaluate the concentrations of …

Background Monitoring serum phosphorus concentrations is crucial in the management of
chronic kidney disease in cats. The diurnal variation of serum phosphorus concentration …

Chronic kidney disease (CKD) in cats is a long-term process characterized by the
irreversible loss of metabolic, endocrine, and excretory functions of the kidneys, usually due …

This report describes the diagnosis and treatment of aldosterone resistance (AR) and
acquired hyperkalemic type IV renal tubular acidosis (RTA) in 2 cats comparable to acquired …

Objectives It has been reported that AB070597, which contains amino acids and peptides,
may prevent the progression of chronic kidney disease (CKD) in cats. The aim of this study …